Companies / Oligon RNA Therapeutics
Oligon RNA Therapeutics
Company
The company does not have a description on this page
Oligon RNA Therapeutics has 2 investors on file, among them CTI Life Sciences Fund and First Bight Ventures. Its site was last checked 17 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from CTI Life Sciences Fund
14 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%), AI & Machine Learning (8%).
See CTI Life Sciences Fund's full profile · Who invests alongside it
More from First Bight Ventures
9 companies on its checked portfolioIts portfolio leans to Advanced Materials & Chemicals (63%), Climate & Energy (25%), Healthcare & Biotech (25%).
See First Bight Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Oligon RNA Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when CTI Life Sciences Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/g.co/investors
# also
GET /v1/companies/g.co
GET /v1/companies/g.co/news